TNFSF10 and Miyoshi myopathy: The selective activity against MM cells is related to the control of TRAIL production by pIL6 which is inserted before the TRAIL sequence within the vector, thus rendering suitable this cell-based approach of anti-MM treatment for future translation in human studies.